Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Karnov Group composes new management team

Karnov Group (Nasdaq: KAR) today announces a new composition of the Group management. The purpose of the change is to ensure the right foundation for further European growth while keeping strong focus on developing the existing businesses in Region South and Region North.The change strengthens the Nordic region with the appointment of a new CEO for Region North, Alexandra Åquist, previously CEO of Norstedts Juridik. She will assume this role from the 1 April 2023, covering the Danish and Swedish markets.    In Region South, Guillaume Deroubaix will assume the position as CEO Region

BE Group publishes the Annual Report for 2022

BE Group’s Annual Report and Company Report for 2022 have now been published and are available on the Group’s website, www.begroup.com. The Swedish version is also available in European Single Electronic Format (ESEF). For further information, please contact:Peter Andersson, President and CEOTel: +46 706 53 76 55, email: peter.andersson@begroup.com Christoffer Franzén, CFOTel: +46 705 46 90 05, email: christoffer.franzen@begroup.com This information is information that BE Group AB (publ) is obliged to make public pursuant to the Securities Market Act. The information was

Vattenfall's Annual and Sustainability Report 2022: Focus on energy transition and to support customers in a demanding time

In 2022, the energy market was marked by the war in Ukraine, which led to a sharp increase in electricity prices throughout Europe. Vattenfall has focused on supporting its customers during a very tough time for many, while at the same time the company has continued to increase investments to succeed with energy transition conversion and electrification.Prices on electricity and gas doubled in 2022 in all of Vattenfall's markets, leading to a very difficult situation for many customers. Vattenfall has therefore supported its customers with advice on energy saving measures, installment plans

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 84 - 29 MARCH 2023 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 40/23 and 42/23.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Thomas France, Investor Communications Partner, tel.: 3315 0451

Safello adds Bankgiro payments in the mobile app

Stockholm, 29 March 2023 | Today Safello, the leading crypto exchange in the Nordics, adds Bankgiro payments via Klarna’s Open Banking API as a payment method in the mobile app. The product enhancement is done to further simplify the customer experience and meet a new type of investor preferences. Safello further lowers the thresholds for customers to invest in cryptocurrencies by enabling Bankgiro payments in its mobile app. The product enhancement is in line with the company's focus to strengthen its core retail product as well as to adopt infrastructure, catering for institutional

Vattenfall and Havfram Wind sign Preferred Supplier Agreement (PSA) for Norfolk projects

March 29th, 2023 – Oslo, Norway – Vattenfall has appointed Havfram Wind as preferred supplier for the installation of wind turbines for Vattenfall’s Norfolk projects in the United Kingdom. The agreement covers transport and installation works over a period of 3 years, utilizing one of Havfram Wind`s newbuild NG20000X Jack-Up Wind Turbine Installation Vessels (WTIV) with a 3,200-ton crane. The works will start in the spring of 2027.Even Larsen, CEO of Havfram Wind, underlined the important position of Vattenfall in the market and their ambitious offshore wind targets for Europe: “Our

Betolar announces updated strategy

Betolar Plc Company release / Insider information 29 March 2023 10:00 AM EEST Betolar announces updated strategy Betolar's Board of Directors has confirmed the company's updated strategy for the years 2023-2025. Target of the strategy is to be the most desirable partner in green transition for the construction, concrete, cement and mining industries. Strategy renewal is part of Betolar's long-term, continuous strategy review process. "Betolar has focused in its strategy on the commercialization of its Geoprime concept and the launch of international operations through

The Probi[®] brand strengthens as Probi takes control on April 1, 2023

The Probi[®] brand is the market leader in Sweden in the probiotic dietary supplement category. By taking over distribution in Sweden from the 1[st] of April 2023, Probi will increase its focus on strengthening the brand on the Swedish market. Sales currently take place in pharmacies, both in physical stores and online.With our own distribution, Probi takes control over the brand- and distribution strategy, which will increase focus on developing the brand and process the sales channels. Since 2022 Probi has built a sales and marketing organization responsible for the Swedish market. "

Change in Terveystalo's Executive Team: Ilari Richardt appointed SVP, Digital Services, Kati Sulin leaves the company

Terveystalo Stock Exchange Release 29 March 2023 at 10.00 a.m. EEST Ilari Richardt, M.Sc., b. 1992, has been appointed Senior Vice President of Digital Services and a member of the Executive Team as of 29 March 2023 as Kati Sulin leaves the company. Richardt has worked at Terveystalo in several key digital business roles for almost 10 years, most recently as Director of Digital product development.  − I am very pleased to appoint Ilari Richardt to his new role and welcome him to our executive team. Ilari is one of Terveystalo’s star talents and the best possible choice to take our

EQT Life Sciences closes Dementia Fund at the hard cap

· The LSP Dementia Fund has held its final close at approximately EUR 260 million, at the hard cap and above its original target fund size of EUR 100 million  · Investors include the Alzheimer’s Association, the European Investment Fund, several global pharmaceutical companies, and insurance companies, amongst other  · The Fund aims to bring new treatments to patients suffering from Dementia, which is one of the greatest healthcare challenges of our time  · Led by Professor Philip Scheltens, one of the world’s leading experts on dementia, the LSP Dementia Fund further

KONE to equip phase three of Xi 'an Xianyang International Airport expansion

KONE Corporation, press release March 29, 2023   KONE Corporation, a global leader in the elevator and escalator industry, has won an order to supply a suite of People Flow® solutions, including 206 KONE elevators, for Xi’an Xianyang international airport in China.  Xi'an Xianyang International Airport is located in Xixian New District, northwest of Xi'an, 26 kilometers from Xi'an city center and 13 kilometers  from Xianyang city center.  The third phase is expected to meet the needs of 83 million passengers and one million ton of cargo and mail by 2030.  KONE's

Notice convening the Annual General Meeting of Lifco AB

The shareholders of Lifco AB (publ), Reg. No. 556465–3185, are hereby invited to attend the Annual General Meeting (AGM) to be held on Friday 28 April 2023, at 11.00 a.m. CEST Bonnierhuset, Torsgatan 21 in Stockholm, Sweden. Right to attend Shareholders who wish to attend the AGM must be recorded in the register of shareholders maintained by Euroclear Sweden AB on Thursday 20 April 2023. In addition, shareholders must notify the Company of their intention to participate in the meeting not later than Monday 24 April 2023. In order to be entitled to participate in the meeting,

Stora Enso’s restated comparison figures for segment reporting

STORA ENSO OYJ STOCK EXCHANGE RELEASE 29 March 2023 at 10:00 EESTStora Enso's segment reporting changed as of 1 January 2023, and the Group has restated the comparative figures for its segment reporting for 2021 and 2022.From 1 January onwards, Stora Enso’s reporting segments are: Packaging Materials, Packaging Solutions, Biomaterials, Wood Products, Forest, and Other.The Paper division was discontinued as of 1 January 2023 and is not reported as a separate segment going forward. From 1 January 2023 onwards, the Maxau and Hylte paper sites are reported in Segment Other until the

Change in Stora Enso’s Group Leadership Team

STORA ENSO OYJ STOCK EXCHANGE RELEASE 29 March 2023 at 10:00 EESTStora Enso has appointed Micaela Thorström as EVP, Legal and General Counsel and a member of the Group Leadership Team. She will start in her new role in April 2023. Micaela Thorström joined Stora Enso in 2015 as Legal Counsel and was appointed Vice President of Group Legal in April 2022. Before joining Stora Enso, she held several senior-level positions at Finnish companies and law firms such as PricewaterhouseCoopers, Hannes Snellman, Lindholm Wallgren Attorneys and Roschier. She has a well-founded and broad legal

UPM Raflatac’s RafCycle™ recycling service wins silver PIDA Sustainable Packaging Design of the Year 2023 award

(UPM Raflatac, Helsinki, 29 March 2023 at 10:00 EEST) – UPM Raflatac’s RafCycle™ recycling service has won a silver Sustainable Packaging Design of the Year 2023 award at the Australasian Packaging Innovation & Design (PIDA) Awards. The announcement came on Tuesday, March 28, at the PIDA Awards Gala Dinner. Coordinated by the Australian Institute of Packaging (AIP), the PIDA awards are designed to recognize companies and individuals who are making a significant difference in their field across Australia and New Zealand. RafCycle recycling service is label release liner

Notice of Extraordinary General Meeting of Brain+ A/S

Notice is hereby given for an Extraordinary General Meeting in Brain+ A/S, CVR. No. 36439440 (“Company”) to be held Thursday, 13 April 2023 at 3 PM (15:00 CEST). The Extraordinary General Meeting will be held at the Company’s registered address at: Købmagergade 53, 3 1150 København K, Denmark.The shareholders of Brain+ A/S are hereby invited to attend an Extraordinary General Meeting on Thursday 13th April 2023 at 15:00 (CEST). The Extraordinary General Meeting will take place at Købmagergade 53, 3. 1150 Copenhagen as a physical event. Please find the invitation and appendices

The Board of Directors in Brain+ A/S intends to execute a rights issue of units of approximately DKK 15.7 million in order to intensify commercial activities

COMPANY ANNOUNCEMENT Copenhagen, Denmark, March 29, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. Today, the Board of Directors in Brain+ A/S (“Brain+” or the “Company”) has resolved to carry out a preferential rights

Notice of Annual General Meeting in Scandinavian Biogas Fuels International AB (PUBL)

The shareholders of Scandinavian Biogas Fuels International AB (publ), 556528-4733, (the “Company”) are hereby summoned to the annual general meeting (“AGM”) on Thursday 27 April 2023 at 14.00 at World Trade Center, Entrance D, Klarabergsviadukten 70, in Stockholm.             The Board of Directors has resolved that shareholders shall have the right to exercise their voting rights in advance through postal voting pursuant to Chapter 7 Section 4 a of the Companies Act (2005:551) and the Company’s Articles of Associations. Therefore, shareholders may choose to exercise their voting rights

BioStock: ExpreS2ion´s CEO on current development and the rights issue

ExpreS2ion Biotechnologies is eagerly awaiting top-line results from the phase III study with its Covid-19 vaccine. Meanwhile the cancer vaccine candidate ES2B-C001 is advancing towards the clinic. BioStock spoke to CEO Bent U. Frandsen to find out more about the development plans and the unit issue that will pave the way for further development.Read the full article at biostock.se : https://www.biostock.se/en/2023/03/expres2ions-ceo-on-current-development-and-the-rights-issue/ This is a press release from BioStock - Connecting Innovation & Capital. https:/

HANZA revises and expands sustainability goals

HANZA's Board of Directors has decided on a revised sustainability strategy with new and expanded sustainability goals. The goals are in line with the Paris Agreement and the UN's global goals for sustainable development and also include social responsibility and corporate governance.The revised sustainability strategy has been developed together with the company's overall strategy "HANZA 2025". Together with the financial goals, the sustainability goals will ensure that HANZA achieves long-term profitable and sustainable growth. Furthermore, HANZA's sustainability strategy means that

HC Andersen Capital Events 29/03: Meet the top management in NNIT & Pharma Equity Group

HC Andersen Capital is hosting a digital event where you can meet and ask questions directly to the top management. It is free for all to attend.NNIT - Presentation of annual report 2022NNIT released its annual report on 23 March 2023. Meet NNIT’s management who will present the results followed by a Q&A session at a virtual live event.   In 2022, NNIT grew its topline on its continuing business by 10% and experienced better growth in the second half of 2022 with most of the growth driven by acquisitions. In 2022, NNIT realized an operating loss (EBIT) of DKK 7m, which is a level that

Biosergen provides Phase 2 clinical development strategy update

Stockholm, Sweden – March 29, 2023 – Biosergen AB (“Biosergen” or the “Company”), today announced an update of the Company’s Phase 2 clinical trial development strategy. Based on the data from the completed Phase I trial, showing no severe side effects associated with BSG005, Biosergen will initiate a Phase 2 trial to show BSG005’s potential to challenge Amphotericin B’s role as a last resort antifungal treatment, as well as to de-risk the further development path of BSG005.Biosergen is pleased to announce its plans to initiate its first Phase 2 clinical trial towards the end of Q2 2023.

Annual Report for Cline Scientific AB (publ), 556867-8238, for the period 1 January – 31 December 2022

Cline Scientific AB (publ) ("Cline" or the "Company") issues the following annual report for 2022.The report is published at www.clinescientific.com/financial-reports   The company is listed on the Nasdaq First North Growth Market. Redeye AB is Cline Scientific's Certified Adviser. The information was submitted for publication via the contact person listed above, at 8:30 CET on 29 March 2023.   For more information, please contact: Patrik Sundh, CEO Email: patrik.sundh@clinescientific.com Phone: +46 703-585 088   About Cline Scientific Cline Scientific develops

There are no items matching the current filter
There are no more items matching the current filter
Back to top